Medicare Enrolled
Dr. Minaxi Jhawer, MBBS
Hematology & Oncology · Englewood, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jhawer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jhawer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jhawer
Dr. Minaxi Jhawer is a hematology & oncology specialist in Englewood, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Jhawer performed 3,135 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Jhawer received a total of $18,858 from 58 pharmaceutical and/or device companies across 318 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jhawer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 39% volume in NJ
$18,858 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,135
Medicare services
Top 39% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
914 | $148 | $325 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
723 | $5 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
586 | $102 | $240 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
335 | $72 | $165 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
172 | $103 | $230 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
152 | $12 | $70 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
149 | $1 | $5 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
57 | $151 | $445 |
| New patient office visit, complex (60-74 min) | 31 | $195 | $460 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
16 | $73 | $185 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$18,858
Total received (2018-2024)
Avg $2,694/year across 7 years
Top 15% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
318
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,384
2023
$814
2022
$1,707
2021
$1,483
2020
$2,643
2019
$3,103
2018
$7,724
Payments by company (2024)
Tempus AI, Inc
$162
E.R. Squibb & Sons, L.L.C.
$161
Merck Sharp & Dohme LLC
$161
Celgene Corporation
$152
SEAGEN INC.
$100
PFIZER INC.
$96
Alexion Pharmaceuticals, Inc.
$78
AstraZeneca Pharmaceuticals LP
$75
Pharmacosmos Therapeutics Inc.
$70
GlaxoSmithKline, LLC.
$39
Aveo Pharmaceuticals, Inc.
$36
Daiichi Sankyo Inc.
$36
Janssen Biotech, Inc.
$34
Ipsen Biopharmaceuticals, Inc
$31
Takeda Pharmaceuticals U.S.A., Inc.
$22
TAIHO ONCOLOGY, INC.
$20
Amgen Inc.
$18
ARRAY BIOPHARMA INC
$17
Aadi Bioscience, Inc.
$17
Incyte Corporation
$16
EMD Serono, Inc.
$16
SERVIER PHARMACEUTICALS LLC
$15
Cumberland Pharmaceuticals, Inc.
$15
Top 3 companies account for 34.9% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$6,009
Ipsen Biopharmaceuticals, Inc
$2,944
Bayer HealthCare Pharmaceuticals Inc.
$2,006
Merck Sharp & Dohme Corporation
$1,565
Exelixis Inc.
$1,398
E.R. Squibb & Sons, L.L.C.
$543
Amgen Inc.
$542
AstraZeneca Pharmaceuticals LP
$358
Daiichi Sankyo Inc.
$324
Celgene Corporation
$324
Merck Sharp & Dohme LLC
$256
Incyte Corporation
$195
Astellas Pharma US Inc
$186
Tempus AI, Inc
$162
Genentech USA, Inc.
$156
PFIZER INC.
$154
Eisai Inc.
$154
Janssen Biotech, Inc.
$150
Novartis Pharmaceuticals Corporation
$142
Pharmacosmos Therapeutics Inc.
$107
SEAGEN INC.
$100
Alexion Pharmaceuticals, Inc.
$94
Biohaven Pharmaceuticals, Inc.
$60
Takeda Pharmaceuticals U.S.A., Inc.
$60
Cumberland Pharmaceuticals, Inc.
$51
Foundation Medicine, Inc.
$50
Regeneron Healthcare Solutions, Inc.
$46
Gilead Sciences, Inc.
$42
Otsuka America Pharmaceutical, Inc.
$42
MorphoSys, US Inc.
$40
GlaxoSmithKline, LLC.
$39
Lexicon Pharmaceuticals, Inc.
$37
TAIHO ONCOLOGY, INC.
$37
Aveo Pharmaceuticals, Inc.
$36
ARRAY BIOPHARMA INC
$32
Aadi Bioscience, Inc.
$31
Teva Pharmaceuticals USA, Inc.
$28
EISAI INC.
$27
AbbVie, Inc.
$27
Sirtex Medical Inc
$27
Kite Pharma, Inc.
$25
AMAG Pharmaceuticals, Inc.
$24
Seagen Inc.
$20
Veloxis Pharmaceuticals, Inc.
$17
EMD Serono, Inc.
$16
Ethicon US, LLC
$15
Shire North American Group Inc
$15
SERVIER PHARMACEUTICALS LLC
$15
Nestle HealthCare Nutrition Inc.
$15
Seattle Genetics, Inc.
$15
ImmunoGen, Inc.
$14
Deciphera Pharmaceuticals Inc.
$14
CTI BioPharma Corp.
$14
Curium US LLC
$13
Agios Pharmaceuticals, Inc.
$12
TOLMAR Pharmaceuticals, Inc.
$12
Janssen Pharmaceuticals, Inc
$12
Boehringer Ingelheim Pharmaceuticals, Inc.
$11
Top 3 companies account for 58.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADYNOVATE · AFINITOR · Abraxane · Alecensa · Aliqopa · Avastin · BENDEKA · BOSULIF · BRAFTOVI · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Caldolor · DARZALEX · Detectnet · ELIGARD · ELREXFIO · EMPLICITI · ENHERTU · ENVARSUS · ERLEADA · EVENITY · Echelon Powered Circular · Elahere · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FRUZAQLA · Fyarro · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · JADENU · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · NURTEC ODT · Neulasta · Nplate · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · Onivyde · PADCEV · PEMAZYRE · PYRUKYND · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RECOTHROM · RYBREVANT · RYDAPT · SANCUSO · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TECENTRIQ · TECVAYLI · TREANDA · TUKYSA · Tibsovo · ULTOMIRIS · Vanflyta · Vectibix · Venclexta · Vitrakvi · Vonjo · XARELTO · XTANDI · Xermelo · Xofigo · Yescarta · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
746
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
ENGLEWOOD HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jhawer is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jhawer experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Jhawer performed 914 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jhawer receive payments from pharmaceutical companies?
Yes. Dr. Jhawer received a total of $18,858 from 58 companies across 318 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jhawer's costs compare to other hematology & oncology specialists in Englewood?
Dr. Jhawer's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jhawer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Englewood
Browse hematology & oncology specialists in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology